ecrin-mdr-crcClinical2012AdenocarcinomaColorectal AdenocarcinomaColorectal cancerAdenocarcinomaColorectal AdenocarcinomaColorectal CancerInterventionalhttps://newmdr.ecrin.org/Study/2121875China3XELOXCapecitabineECRIN MDRNot providedfalseEfficacy and Safety Study of a Modified XELOX Regimen in First-Line Treatment of Metastatic Colorectal AdenocarcinomaThis is an open-label, phase II study to evaluate the efficacy and safety of a modified regimen of oxaliplatin and capecitabine on metastatic colorectal adenocarcinoma in the first-line therapy.2012-03-152121875NCT01552967